Caption Management, LLC Intra Cellular Therapies, Inc. Call Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$64.76 - $79.84 $5.09 Million - $6.28 Million	-78,600 Reduced 56.71%	60,000 $4.11 Million
Q1 2024 May 15, 2024	BUY	$64.37 - $75.65 $8.79 Million - $10.3 Million	136,500 Added 6500.0%	138,600 $9.59 Million
Q4 2023 Feb 14, 2024	SELL	$46.37 - $73.65 $2.45 Million - $3.9 Million	-52,900 Reduced 96.18%	2,100 $150,000
Q3 2023 Nov 14, 2023	BUY	$52.09 - $64.1 $2.08 Million - $2.56 Million	40,000 Added 266.67%	55,000 $2.86 Million
Q2 2023 Aug 14, 2023	SELL	$54.67 - $66.44 $820,050 - $996,600	-15,000 Reduced 50.0%	15,000 $949,000
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $1.31 Million - $1.71 Million	30,000 New	30,000 $1.62 Million
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $2.58 Million - $3.94 Million	60,000 New	60,000 $3.43 Million
Q1 2022 May 13, 2022	SELL	$38.74 - $62.09 $8.02 Million - $12.9 Million	-207,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$35.2 - $53.42 $2.75 Million - $4.18 Million	78,200 Added 60.71%	207,000 $10.8 Million
Q3 2021 Nov 12, 2021	BUY	$28.72 - $42.49 $244,120 - $361,165	8,500 Added 7.07%	128,800 $4.8 Million
Q2 2021 Aug 16, 2021	BUY	$29.3 - $44.5 $1.52 Million - $2.31 Million	51,800 Added 75.62%	120,300 $4.91 Million
Q1 2021 May 17, 2021	BUY	$30.8 - $39.51 $1.19 Million - $1.52 Million	38,500 Added 128.33%	68,500 $2.32 Million
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $16.2 Million - $22.3 Million	-693,600 Reduced 95.85%	30,000 $954,000
Q2 2020 Aug 14, 2020	BUY	$14.35 - $26.64 $8.29 Million - $15.4 Million	577,500 Added 395.28%	723,600 $18.6 Million
Q1 2020 May 15, 2020	SELL	$12.31 - $33.12 $8.1 Million - $21.8 Million	-658,200 Reduced 81.84%	146,100 $2.25 Million
Q4 2019 Feb 13, 2020	BUY	$7.26 - $38.49 $8,712 - $46,188	1,200 Added 0.15%	804,300 $27.6 Million
Q3 2019 Nov 14, 2019	BUY	$7.47 - $14.03 $3.6 Million - $6.75 Million	481,400 Added 149.64%	803,100 $6 Million
Q2 2019 Aug 13, 2019	BUY	$10.65 - $14.29 $1.28 Million - $1.72 Million	120,200 Added 59.65%	321,700 $4.18 Million
Q1 2019 May 14, 2019	BUY	$10.9 - $14.09 $2.2 Million - $2.84 Million	201,500 New	201,500 $2.45 Million

Others Institutions Holding ITCI

# of Institutions

379

Shares Held

84.1M

Call Options Held

319K

Put Options Held

143K

Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$795 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.32M
Shares

$522 Million
0.01% of portfolio
Jpmorgan Chase & CO New York, NY

5.29M
Shares

$436 Million
0.03% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

3.85M
Shares

$318 Million
1.4% of portfolio
Avoro Capital Advisors LLC New York, NY

3.05M
Shares

$252 Million
3.36% of portfolio

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.79B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account